All of Us Research Program
Do you want to change the future of health? The Froedtert & MCW health network is part of the National Institutes of Health All of Us Research Program. It has a simple mission — speed up health research breakthroughs. To do this, All of Us is asking one million people to share their health information. Learn how you can help make a difference by joining the All of Us Research Program.
A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury (RISCIS)
The purpose of this trial is to evaluate the efficacy and safety of riluzole in the treatment of patients with acute SCI.
Investigator: Shekar N. Kurpad, MD, PhD
Status: Currently enrolling
Progesterone for Traumatic Brain Injury; Experimental Clinical Treatment (PROTECT)
Keywords
TBI, Exception from Informed Consent
Image-Based Predictions of Hemodynamics
The research studies blood flow in aneurysm for the selection of treatment. (NIH RO1: HL115267)
Stroke Recruitment Database
The database is designed specifically to serve as a screening and recruitment tool for stroke researchers in the greater Milwaukee Area, matching stroke survivors willing to contribute to science as research participants with study coordinators seeking to populate their studies with individuals meeting their particular inclusion/exclusion criteria.
Nilotinib in Parkinson's Disease (NILO-PD)
This is a randomized, double-blind, placebo-controlled, phase IIa, parallel-group, two-cohort study to define the safety, tolerability, clinical and exploratory biological activity of the chronic administration of Nilotinib in participants with Parkinson’s disease (PD).
Keywords
Parkinson’s Disease, PD, Nilotinib
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) (FORTITUDE-ALS)
This is a phase 2, multicenter, double-blind, randomized, dose-ranging, placebo-controlled study to evaluate the efficacy, safety and tolerability of CK-2127107 in patients with amyotrophic lateral sclerosis (ALS).
Keywords
Amyotrophic Lateral Sclerosis, ALS, CK-2127107
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
This is a multicenter, double-blind, placebo-controlled study to assess the efficacy and safety of H.P. Acthar® Gel in the treatment of subjects with amyotrophic lateral sclerosis (ALS). MNK14042068
Keywords
Amyotrophic Lateral Sclerosis, ALS, Acthar
MRI Study of Intervertebral Disc Degeneration: Evaluation of the Vascular Characteristics in Patients with Chronic Low Back Pain due to Degenerative Disc Disease
Keywords
Low back pain, degenerative disc disease, healthy volunteers
Diffusion Tensor Imaging of the Human Spinal Cord
Keyword
Spinal Cord Injury
Predicting the Outcome of Cervical Spondylotic Myelopathy Using Diffusion Tensor Imaging
Keyword
Cervical surgery
Medical College of Wisconsin Brain Tumor and Brain Tissue Bank
Keyword
Brain Tissue Bank
Crash Injury Research Engineering Network
Keywords
Crash, Injury
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)
This is an international, randomized, double-blind, controlled study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in patients with newly diagnosed, surgically resected, EGFRvIII-positive glioblastoma
Keywords
Glioblastoma, Brain Tumors, Rindopepimut, vaccination, EGFRvIII
Interstitial Cystitis: Examination of the Central Autonomic Network (ICECAN)
Keywords
Interstitial Cystitis, IC, Bladder Pain Syndrome, BPS, Myofascial Pelvic Pain, MPP, Chronic Pelvic Pain, CPP, Autonomic Nervous System, ANS, Beta Blocker
Restoration of mitochondrial function in functional pain and autonomic disorders-2
Keywords
Abnormal mitochondrial bioenergetics, functional gastrointestinal disorders, FGID, Cardiopulmonary exercise testing, CPET